Development of an immunocytokine, IL-2-183B2scFv, for targeted immunotherapy of ovarian cancer.
Zhang X, Feng J, Ye X, Yao Y, Zhou P, Chen X. Development of an immunocytokine, IL-2-183B2scFv, for targeted immunotherapy of ovarian cancer. Gynecol Oncol. 2006 Dec; 103(3):848-52.